col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


16 Ergebisse       Seite 1

 [1] 
Springer-Verlag: Rheumatology and Therapy
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Jan―13 Impact of the COVID-19 Pandemic on People Living with Rheumatoid Arthritis: Experiences and Preferences in Accessing Healthcare Across Five Countries Alain Saraux, Licia Maria Henrique da Mota, Sanjay Dixit, Allan Gibofsky, Tsukasa Matsubara, Amy Mulvey, et al. (+4)
2 [GO] 2024―Jan―06 Characteristics of COVID-19 and Impact of Disease Activity in Patients with Adult-Onset Still’s Disease Xinyue Hong, Xiaoming Wang, Ningqi Dai, Yue Sun, Honglei Liu, Xiaobing Cheng, et al. (+9)
3 [GO] 2024―Jan―04 Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases and Serum Antibody Changes Post-Omicron Variant Infection Xiaowei Zhang, Yifei Li, Chunqing Dai, Yaya Chu, Chaoqi Luan, Guihong Wang
4 [GO] 2023―Jun―19 The Recent Outbreak of COVID-19 in China During the Omicron Variant Predominance: Clinical Features and Outcomes in Patients with Autoimmune Inflammatory Rheumatic Diseases Yan Geng, Yong Fan, Xuerong Deng, Yu Wang, Juan Zhao, Lanlan Ji, et al. (+7)
5 [GO] 2022―Dez―02 COVID-19 in Patients with Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization Hossein Azizi, Hanie Karimi, Mahdi Kazemi, Somaye Sadat Rezaei, Amirhossein Parsaei, Mohammad Aghaali, et al. (+4)
6 [GO] 2022―Jun―15 Plasma Exchange in a Patient with Immune Thrombocytopenia Associated with Antiphospholipid Syndrome Hospitalized for COVID-19 Federico Boggio, Alessandro Ciavarella, Sara Arcudi, Roberta Gualtierotti, Raffaella Rossio, Francesco Tafuri, et al. (+2)
7 [GO] 2022―Jun―14 Letter to the Editor Regarding “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?” Josef Finsterer
8 [GO] 2022―Mai―27 A Response to: Letter to the Editor Regarding the Article: “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?” Alexandros A. Drosos, Eleftherios Pelechas, Vassiliki Drossou, Paraskevi V. Voulgari
9 [GO] 2022―Mai―22 COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis Atul Deodhar, Suleman Bhana, Kevin Winthrop, Lianne S. Gensler
10 [GO] 2022―Feb―02 Colchicine Against SARS-CoV-2 Infection: What is the Evidence? Alexandros A. Drosos, Eleftherios Pelechas, Vassiliki Drossou, Paraskevi V. Voulgari
11 [GO] 2021―Nov―16 Seronegative Erosive Arthritis Following SARS-CoV-2 Infection Alexandros A. Drosos, Eleftherios Pelechas, Paraskevi V. Voulgari
12 [GO] 2021―Sep―16 Antirheumatic Drug Intake Influence on Occurrence of COVID-19 Infection in Ambulatory Patients with Immune-Mediated Inflammatory Diseases: A Cohort Study Debellemanière Guillaume, Bouvet Magalie, Elahi Sina, Salah-Mabed Imène, Vayr Frédéric, Dubois Mathieu, et al. (+19)
13 [GO] 2021―Jul―23 TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case-Control Study Mansour Salesi, Behrokh Shojaie, Ziba Farajzadegan, Naghmeh Salesi, Erfan Mohammadi
14 [GO] 2021―Mai―24 The Rise and Fall of Hydroxychloroquine with the COVID-19 Pandemic: Narrative Review of Selected Data Wei Tang, Leila Khalili, Jon Giles, Yevgeniya Gartshteyn, Teja Kapoor, Cathy Guo, et al. (+3)
15 [GO] 2020―Jul―28 Virtual Rheumatology During COVID-19: A Personal Perspective Jane Dacre
16 [GO] 2020―Mai―29 Rheumatology Care in the Face of COVID-19 Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
 [1] 

16 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.003 sec